Functional Characterization of PPAR^-Dependent Gene Networks in Macrophages.
巨噬细胞中 PPAR^依赖性基因网络的功能表征。
基本信息
- 批准号:8355985
- 负责人:
- 金额:$ 41.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-05-01 至
- 项目状态:未结题
- 来源:
- 关键词:2,4-thiazolidinedione3-DimensionalActinsAdipocytesAdipose tissueAnimalsAnti-Inflammatory AgentsAnti-inflammatoryCell NucleusChromatinCollaborationsComplementComplexDevelopmentDietEnvironmentEvaluationExhibitsFatty AcidsFatty acid glycerol estersFutureGene ExpressionGene TargetingGenesInflammatoryInflammatory ResponseInsulinInsulin ResistanceInterferonsInterleukin-4InvestigationLigandsLocationMacrophage ActivationMaintenanceMediatingMethodsMolecularMovementNon-Insulin-Dependent Diabetes MellitusNuclearNuclear ReceptorsObesityPathway interactionsPeroxisome Proliferator-Activated ReceptorsPhenotypePhysiologicalPlayPolyunsaturated Fatty AcidsProductionRNARegulationRepressionRoleShapesSignal PathwaySignal TransductionTLR4 geneTestingTherapeuticTherapeutic EffectTherapeutic InterventionThiazolidinedionesTissuesToll-like receptorsTranscriptbaseblood glucose regulationcytokinediabeticgenome wide association studygenome-wideimprovedin vivoinnovationinsulin sensitivitylong chain fatty acidmacrophagenovel strategiespalmitoleic acidpreventreceptorresponse
项目摘要
Project 3 will investigate transcriptional networks in macrophages that influence Insulin resistance. Our proposed studies will primarily focus on understanding unexpected physiological and cellular consequences of deletion of the NCoR co-repressor in macrophages and on deflning the molecular mechanisms by which macrophage PPARy contributes to normal glucose homeostasis and insulin sensitizing effects of
thiazolidinediones (TZDs). These lines of investigation will complement studies performed in Projects 1 and 2 to improve our understanding of central pathogenic mechanisms that drive the development of insulin resistance. Speciflc Aim 1 will test the hypothesis that macrophage-speciflc disruption of NCor results in enhanced insulin sensitivity due to de-repression of LXR and/or PPARy target genes that drive production of anti-inflammatory fatty acids. These studies have the potential to identify a fundamentally new pathway by which macrophages influence insulin resistance that may be amendable to therapeutic intervention. Specific Aim 2 will investigate mechanisms by which macrophage PPARy contributes to normal glucose homeostasis
and anti-diabetic effects of TZDs. We will test the hyothesis that the genome-wide locations and functions of PPARy are compromised in adipose tissue macrophages of obese adipose tissue and are restored by insulin-sensitizing PPARy ligands. These studies will make use of new in vivo approaches for determining macrophage-specific PPAR location and function in adipose tissue that do not require extensive purification
methods. Studies in Specific Aim 3 will be performed in collaboration with Project 2 to test the hypothesis that alternative macrophage activation alters the chromatin interactome so as to facilitate PPARy-dependent gene expression and antagonize TLR4-dependent gene expression. These studies will test a new concept
for understanding how anti-inflammatory and pro-inflammatory signals are integrated at a 3 dimensional level in the nucleus.
项目3将研究巨噬细胞中影响胰岛素抵抗的转录网络。我们建议的研究将主要集中在了解巨噬细胞中NCoR共抑制物缺失带来的意想不到的生理和细胞后果,以及降低巨噬细胞PPARy促进正常血糖稳态和胰岛素增敏效应的分子机制。
噻唑烷二酮类(TZDS)。这些研究将补充项目1和项目2中进行的研究,以提高我们对推动胰岛素抵抗发展的中央致病机制的理解。Speciflc Aim 1将测试这一假设,即巨噬细胞特异性干扰NCoR导致胰岛素敏感性增强,这是由于LXR和/或PPARy靶基因的抑制导致抗炎脂肪酸的产生。这些研究有可能确定巨噬细胞影响胰岛素抵抗的一条全新的途径,该途径可能可用于治疗干预。特殊目标2将研究巨噬细胞PPARy促进正常血糖稳态的机制
以及TZDS的抗糖尿病作用。我们将测试PPARy在整个基因组中的位置和功能在肥胖脂肪组织的脂肪组织巨噬细胞中受到损害,并通过胰岛素增敏的PPARy配体恢复。这些研究将利用新的体内方法来确定脂肪组织中巨噬细胞特异性PPAR的位置和功能,而不需要广泛的纯化
方法:研究方法。具体目标3的研究将与项目2合作进行,以验证以下假设:交替的巨噬细胞激活改变染色质相互作用体,从而促进依赖PPARy的基因表达,并拮抗依赖TLR4的基因表达。这些研究将测试一个新的概念
以了解抗炎和促炎信号是如何在细胞核内的三维水平上整合的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christopher K Glass其他文献
Pharmacological correction of a defect in PPAR-γ signaling ameliorates disease severity in Cftr-deficient mice
对 PPAR-γ信号通路缺陷的药理学纠正改善了 Cftr 缺陷小鼠的疾病严重程度
- DOI:
10.1038/nm.2101 - 发表时间:
2010-02-14 - 期刊:
- 影响因子:50.000
- 作者:
Gregory S Harmon;Darren S Dumlao;Damian T Ng;Kim E Barrett;Edward A Dennis;Hui Dong;Christopher K Glass - 通讯作者:
Christopher K Glass
Sterols and oxysterols in immune cell function
免疫细胞功能中的固醇和氧固醇
- DOI:
10.1038/ni.2681 - 发表时间:
2013-08-20 - 期刊:
- 影响因子:27.600
- 作者:
Nathanael J Spann;Christopher K Glass - 通讯作者:
Christopher K Glass
Christopher K Glass的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christopher K Glass', 18)}}的其他基金
A Cardiovascular-NASH disease nexus: Common Mechanisms and Treatments?
心血管疾病与 NASH 疾病的关系:常见机制和治疗方法?
- 批准号:
10683961 - 财政年份:2020
- 资助金额:
$ 41.77万 - 项目类别:
Macrophage-specific targeting of LXRs in CVD and NASH
CVD 和 NASH 中 LXR 的巨噬细胞特异性靶向
- 批准号:
10262918 - 财政年份:2020
- 资助金额:
$ 41.77万 - 项目类别:
A Cardiovascular-NASH disease nexus: Common Mechanisms and Treatments?
心血管疾病与 NASH 疾病的关系:常见机制和治疗方法?
- 批准号:
10262913 - 财政年份:2020
- 资助金额:
$ 41.77万 - 项目类别:
Macrophage-specific targeting of LXRs in CVD and NASH
CVD 和 NASH 中 LXR 的巨噬细胞特异性靶向
- 批准号:
10461064 - 财政年份:2020
- 资助金额:
$ 41.77万 - 项目类别:
A Cardiovascular-NASH disease nexus: Common Mechanisms and Treatments?
心血管疾病与 NASH 疾病的关系:常见机制和治疗方法?
- 批准号:
10461059 - 财政年份:2020
- 资助金额:
$ 41.77万 - 项目类别:
Macrophage-specific targeting of LXRs in CVD and NASH
CVD 和 NASH 中 LXR 的巨噬细胞特异性靶向
- 批准号:
10683973 - 财政年份:2020
- 资助金额:
$ 41.77万 - 项目类别:
相似海外基金
REU Site: Design, Create, and Innovate 3-Dimensional User Interfaces to Improve Human Sensory and Motor Performance in Virtual Environments (HUMANS MOVE)
REU 网站:设计、创建和创新 3 维用户界面,以提高虚拟环境中的人类感官和运动表现 (HUMANS MOVE)
- 批准号:
2349771 - 财政年份:2024
- 资助金额:
$ 41.77万 - 项目类别:
Standard Grant
CAREER: Atomic-level understanding of stability and transition kinetics of 3-dimensional interfaces under irradiation
职业:对辐照下 3 维界面的稳定性和转变动力学的原子水平理解
- 批准号:
2340085 - 财政年份:2024
- 资助金额:
$ 41.77万 - 项目类别:
Continuing Grant
Artificial fabrication of 3-dimensional noncollinear magnetic order and magnetization manipulation by spin torque
三维非共线磁序的人工制造和自旋转矩磁化操纵
- 批准号:
23H00232 - 财政年份:2023
- 资助金额:
$ 41.77万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Understanding of 3-dimensional seismic behavior of RC frame high-speed railway/highway viaducts using FE analysis
使用有限元分析了解 RC 框架高速铁路/公路高架桥的 3 维抗震性能
- 批准号:
23H01489 - 财政年份:2023
- 资助金额:
$ 41.77万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Modernization of 3-dimensional printing capabilities at the Aquatic Germplasm and Genetic Resource Center
水产种质和遗传资源中心 3 维打印能力的现代化
- 批准号:
10736961 - 财政年份:2023
- 资助金额:
$ 41.77万 - 项目类别:
The 3-dimensional nest of the honey bee: organization, development, and impact on colony function
蜜蜂的 3 维巢穴:组织、发育及其对蜂群功能的影响
- 批准号:
2216835 - 财政年份:2023
- 资助金额:
$ 41.77万 - 项目类别:
Standard Grant
Research on high-density 3-dimensional polymer optical waveguide device for photonics-electronics convergence
光电子融合高密度三维聚合物光波导器件研究
- 批准号:
23H01882 - 财政年份:2023
- 资助金额:
$ 41.77万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Scaff-Net: 3 Dimensional multiphoton polymerisation printed scaffolds for medium throughput recording from stem cell derived human cortical networks.
Scaff-Net:3 维多光子聚合打印支架,用于从干细胞衍生的人类皮质网络进行中等通量记录。
- 批准号:
EP/X018385/1 - 财政年份:2023
- 资助金额:
$ 41.77万 - 项目类别:
Research Grant
3-dimensional prompt gamma imaging for online proton beam dose verification
用于在线质子束剂量验证的 3 维瞬发伽马成像
- 批准号:
10635210 - 财政年份:2023
- 资助金额:
$ 41.77万 - 项目类别:
Equipment: MRI: Track 1 Acquisition of a 3-Dimensional Nanolithography Instrument
设备:MRI:轨道 1 获取 3 维纳米光刻仪器
- 批准号:
2320636 - 财政年份:2023
- 资助金额:
$ 41.77万 - 项目类别:
Standard Grant














{{item.name}}会员




